Se-Natal 19
RxNorm 1313925· .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM PANTOTHENATE, CALCIUM CARBONATE, FERROUS FUMARATE, ZINC OXIDE AND DOCUSATE SODIUM· ORAL
Vitamin C [EPC], Vitamin D [EPC], Vitamin B12 [EPC] · Seton Pharmaceuticals
Boxed Warning
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Indications and usage
INDICATIONS Se-Natal 19 tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. Se-Natal 19 tablets are also useful in improving the nutritional status of women prior to conception.
Dosage and administration
DOSAGE AND ADMINISTRATION One tablet daily, or as directed by a physician.
Warnings
WARNINGS Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B 12 is deficient. WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Contraindications
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Drug interactions
DRUG INTERACTIONS Prescriber should be aware of a number of iron/drug interactions, including antacids, tetracyclines, or fluoroquinolones.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- hyperhidrosis1
- influenza1
- nasopharyngitis1
- off label use1
- pain1
- palpitations1
- product use in unapproved indication1
- product used for unknown indication1
Adverse reactions (label)
ADVERSE REACTIONS Adverse reactions with iron therapy may include GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
KR · 한국Products in Korea (7058)
- 개비스콘츄어블정(유)옥시레킷벤키저
- 개비스콘츄어블정(유)옥시레킷벤키저
- 개비스콘츄어블정(유)옥시레킷벤키저
- 개비스콘페퍼민트현탁액(유)옥시레킷벤키저
- 개비스콘페퍼민트현탁액(유)옥시레킷벤키저
- 개비스콘페퍼민트현탁액(유)옥시레킷벤키저
- 개비스콘페퍼민트현탁액(유)옥시레킷벤키저
- 개비스콘페퍼민트현탁액(유)옥시레킷벤키저
- 개비스콘더블액션현탁액(유)옥시레킷벤키저
- 개비스콘더블액션현탁액(유)옥시레킷벤키저
- 개비스콘더블액션현탁액(유)옥시레킷벤키저
- 개비스콘더블액션현탁액(유)옥시레킷벤키저
- 개비스콘더블액션현탁액(유)옥시레킷벤키저
- 리버쿨에스연질캡슐(유)한풍제약
- 리버쿨에스연질캡슐(유)한풍제약
- 마진가에프츄어블정(유)한풍제약
- 바이오파워정(유)한풍제약
- 바이오파워정(유)한풍제약
- 바이오파워캡슐(유)한풍제약
- 바이오파워캡슐(유)한풍제약
View more: Full FDA label on DailyMed →Label effective 20250224